| Issue Date | Title | Type | Author(s) |
| 1995 | A recurrent translocation, t(3;11)(q21;q13), found in two distinct cases of acute myeloid leukemia | Articulo | Cigudosa, J.C. (Juan Cruz) ; Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores); Marin, J. (Julián); Bengoechea, E. (Enrique); Gullon, A. (Arturo) |
| 1995 | A variant t(14;17) in acute promyelocytic leukemia. Positive response to retinoic acid treatment | Articulo | Cigudosa, J.C. (Juan Cruz); Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores); Marin, J. (Julián); Bengoechea, E. (Enrique); Gullon, A. (Arturo) |
| 1994 | CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro | Articulo | Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Golvano, J.J. (José Javier); Prieto, I. (Isidro); Civeira, M.P. (María Pilar); Gullon, A. (Arturo); Sarin, P.S. (Prem S.); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1997 | Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations | Articulo | Calasanz-Abinzano, M.J. (Maria Jose); Cigudosa, J.C. (Juan Cruz); Odero, M.D. (Maria Dolores); Ferreira, C. (C.); Ardanaz, M.T. (M.T.); Fraile, A. (A.); Carrasco, J. (J.L.); Sole, F. (Francesc); Cuesta, B. (Braulia); Gullon, A. (Arturo) |
| 1993 | Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells | Articulo | Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Larrea, E. (Esther); Golvano, J.J. (José Javier); Prieto, I. (Inés); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1996 | Further insights on the inhibition of HIV type 1 infection in vitro by CD4-modified synthetic peptides containing phenylalanine | Articulo | Prieto, I. (Isidro); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Golvano, J.J. (José Javier); Civeira, M.P. (María Pilar); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1991 | Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide | Articulo | Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Golvano, J.J. (José Javier); Gullon, A. (Arturo); Civeira, M.P. (María Pilar); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1992 | Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct | Articulo | Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1994 | Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr | Articulo | Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Golvano, J.J. (José Javier); Prieto, I. (Isidro); Gullon, A. (Arturo); Soto, M.J. (María José); Labarga, P. (Pablo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
| 1990 | Polarity of immunogens: implications for vaccine design | Articulo | Golvano, J.J. (José Javier); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Gullon, A. (Arturo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco) |
